Isoprinosine in the treatment of herpes virus infections in children with leukaemia and malignant lymphoma.
Isoprinosine was given to 15 children with lymphoblastic diseases and 3 adults during infections with herpes viruses - herpes simplex (HSV) and varicella-zoster viruses (VZV). The control group included 7 children who had previously suffered from infections with HSV and VZV without being treated with isoprinosine. The clinical observations showed a significant inhibitory effect of isoprinosine on viral infections, with the duration of the disease being shortened considerably. The authors think isoprinosine treatment to be justified in viral infections, especially in children with neoplastic diseases, because of the immunostimulating action of the drug, rapid clinical improvement and good tolerance of the drug.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004361:Drug Tolerance; D005260:Female; D006566:Herpesviridae Infections / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007288:Inosine / Q000031:analogs & derivatives*; D007542:Inosine Pranobex / Q000627:therapeutic use*; D007938:Leukemia / Q000150:complications*; D008223:Lymphoma / Q000150:complications*; D008297:Male
D007288:Inosine; D007542:Inosine Pranobex